Cargando…

A natural DYRK1A inhibitor as a potential stimulator for β‐cell proliferation in diabetes

Detalles Bibliográficos
Autores principales:	Zheng, Mengzhu, Zhang, Qingzhe, Zhang, Chengliang, Wu, Canrong, Yang, Kaiyin, Song, Zhuorui, Wang, Qiqi, Li, Chen, Zhou, Yirong, Chen, Jiachun, Li, Hua, Chen, Lixia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288015/ https://www.ncbi.nlm.nih.gov/pubmed/34323401 http://dx.doi.org/10.1002/ctm2.494

Ejemplares similares

Furin: A Potential Therapeutic Target for COVID-19
por: Wu, Canrong, et al.
Publicado: (2020)

Inhibition of DYRK1A Stimulates Human β-Cell Proliferation
por: Dirice, Ercument, et al.
Publicado: (2016)

A natural inhibitor of kidney-type glutaminase: a withanolide from Physalis pubescens with potent anti-tumor activity
por: Wu, Canrong, et al.
Publicado: (2017)

Regeneration of Pancreatic β-Cells for Diabetes Therapeutics by Natural DYRK1A Inhibitors
por: Guo, Yichuan, et al.
Publicado: (2022)

Inhibition of DYRK1A and GSK3B induces human β-cell proliferation
por: Shen, Weijun, et al.
Publicado: (2015)

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
por: Wu, Canrong, et al.
Publicado: (2020)

Targeting DYRK1B suppresses the proliferation and migration of liposarcoma cells
por: Chen, Hua, et al.
Publicado: (2017)

DYRK1A antagonists rescue degeneration and behavioural deficits of in vivo models based on amyloid-β, Tau and DYRK1A neurotoxicity
por: Zhu, Bangfu, et al.
Publicado: (2022)

Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A
por: Widowati, Esti Wahyu, et al.
Publicado: (2018)

NFATc1 phosphorylation by DYRK1A increases its protein stability
por: Liu, Heng, et al.
Publicado: (2017)

DCAF7/WDR68 is required for normal levels of DYRK1A and DYRK1B
por: Yousefelahiyeh, Mina, et al.
Publicado: (2018)

Differential maturation and chaperone dependence of the paralogous protein kinases DYRK1A and DYRK1B
por: Papenfuss, Marco, et al.
Publicado: (2022)

DYRK1A activates NFATC1 to increase glioblastoma migration
por: Liu, Heng, et al.
Publicado: (2021)

DYRK1A-mediated PLK2 phosphorylation regulates the proliferation and invasion of glioblastoma cells
por: Tan, Shichuan, et al.
Publicado: (2023)

DYRK1A Kinase Inhibitors Promote β-Cell Survival and Insulin Homeostasis
por: Barzowska, Agata, et al.
Publicado: (2021)

GSK-3β, FYN, and DYRK1A: Master Regulators in Neurodegenerative Pathways
por: Demuro, Stefania, et al.
Publicado: (2021)

The Omnipresence of DYRK1A in Human Diseases
por: Deboever, Estelle, et al.
Publicado: (2022)

Natural Aristolactams and Aporphine Alkaloids as Inhibitors of CDK1/Cyclin B and DYRK1A
por: Marti, Guillaume, et al.
Publicado: (2013)

DYRK1A inhibitors leucettines and TGF-β inhibitor additively stimulate insulin production in beta cells, organoids, and isolated mouse islets
por: Pucelik, Barbara, et al.
Publicado: (2023)

Tumor Suppressor DYRK1A Effects on Proliferation and Chemoresistance of AML Cells by Downregulating c-Myc
por: Liu, Qiang, et al.
Publicado: (2014)

Emerging roles of DYRK2 in cancer
por: Tandon, Vasudha, et al.
Publicado: (2021)

A novel de novo heterozygous DYRK1A mutation causes complete loss of DYRK1A function and developmental delay
por: Lee, Kyu-Sun, et al.
Publicado: (2020)

Ocular Phenotype Associated with DYRK1A Variants
por: Méjécase, Cécile, et al.
Publicado: (2021)

Functional Roles of DYRK2 as a Tumor Regulator
por: Mochimaru, Yuta, et al.
Publicado: (2023)

Dyrk1A Positively Stimulates ASK1-JNK Signaling Pathway during Apoptotic Cell Death
por: Choi, Hyoung Kyoung, et al.
Publicado: (2011)

Protein kinase DYRK2 is an E3-ligase specific molecular assembler
por: Maddika, Subbareddy, et al.
Publicado: (2009)

DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3
por: Thompson, Benjamin J., et al.
Publicado: (2015)

Inhibition of DYRK1A-EGFR axis by p53-MDM2 cascade mediates the induction of cellular senescence
por: Xu, Xiuhua, et al.
Publicado: (2019)

Selective inhibition reveals the regulatory function of DYRK2 in protein synthesis and calcium entry
por: Wei, Tiantian, et al.
Publicado: (2022)

Clinical phenotype of ASD-associated DYRK1A haploinsufficiency
por: Earl, Rachel K., et al.
Publicado: (2017)

TROAP switches DYRK1 activity to drive hepatocellular carcinoma progression
por: Li, Lei, et al.
Publicado: (2021)

Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome
por: Ashford, Anne L., et al.
Publicado: (2015)

K63-linked ubiquitination of DYRK1A by TRAF2 alleviates Sprouty 2-mediated degradation of EGFR
por: Zhang, Pengshan, et al.
Publicado: (2021)

Mirk/dyrk1B Kinase in Ovarian Cancer
por: Friedman, Eileen
Publicado: (2013)

Discovery and Characterization of Selective and Ligand-Efficient DYRK Inhibitors
por: Henderson, Scott H., et al.
Publicado: (2021)

DYRK2 downregulation in colorectal cancer leads to epithelial–mesenchymal transition induction and chemoresistance
por: Wu, Chunrong, et al.
Publicado: (2022)

Selectivity Profiling and Biological Activity of Novel β-Carbolines as Potent and Selective DYRK1 Kinase Inhibitors
por: Rüben, Katharina, et al.
Publicado: (2015)

Sequential phosphorylation of NDEL1 by the DYRK2-GSK3β complex is critical for neuronal morphogenesis
por: Woo, Youngsik, et al.
Publicado: (2019)

Drosophila Dyrk2 Plays a Role in the Development of the Visual System
por: Luebbering, Nathan, et al.
Publicado: (2013)

One-carbon cycle alterations induced by Dyrk1a dosage
por: Delabar, Jean-Maurice, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d1lr0l660st5q1pbo0iv1t3kkl